Spatial multi-omics landscape of colorectal cancer macro- and micrometastases
12 affiliations
- 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 2Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 3Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 4Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 5Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 6Department of GI Radiation Oncology, Division of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 8Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 9Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 10Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA
- 11Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: [email protected]
- 12Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: [email protected]
Abstract
Colorectal cancer (CRC) metastases frequently recur due to minimal residual disease (MRD) and persistent micrometastases after therapy. Here, we performed spatial multimodal profiling using spot-level and high-resolution spatial transcriptomics, multi-regional whole-genome sequencing following laser-capture microdissection, and high-plex protein imaging to map 49 tumors from 19 patients, encompassing paired primary CRC and matched liver (CLiM) and lung (CLuM) metastases. Phylogenetic reconstruction revealed that liver micrometastases (CLiMi) arose from early clonal divergences and harbored a stem-like, quiescent state consistent with metastatic dormancy. Spatially, we uncovered distinct stromal barriers: macrometastases were encapsulated by myofibroblasts, whereas micrometastases were surrounded by immunosuppressive niches characterized by T cell exhaustion and distinct ligand-receptor signaling networks. Notably, we identified a CLiMi-specific six-gene signature associated with MRD status, disease-free survival, and chemotherapy resistance across multiple independent cohorts. These findings elucidate the spatial evolutionary landscape of CRC metastases and provide tissue-based spatially validated biomarkers for surveillance and therapeutic targeting.
Related
- Global research landscape of ferroptosis in colorectal cancer: a multi-database bibliometric analysis (2017–2025)
- Integrated scRNA‐Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer‐Associated Fibroblast–Dominant Domains in Colorectal Cancer
- 1132 Spatial mapping and significance of the IL-12 pathway in human colorectal cancer
- Antibody–drug conjugates in colorectal cancer: target biology, resistance, and the clinical-trial landscape
- SPATNIC enables H&E-grounded cancer-cell identification across spatial and single-cell transcriptomic modalities in colorectal cancer
BibTeX
@article{liu2026spatial,
title = {{Spatial multi-omics landscape of colorectal cancer macro- and micrometastases}},
author = {Yunhe Liu and Akshaya S. Jadhav and Yuwen Pan and Jianlong Liao and Isha Khanduri and Yunhe Liu and Riham Katkhuda and Wei Lü and Kyung Serk Cho and Zhimin Tong and Tieling Zhou and Kangyu Lin and Baohua Sun and Mei Jiang and Sharia D. Hernandez and Idania Carolina Lubo Julio and Patrick M. Brennan and Guangsheng Pei and Kai Yu and Yibo Dai and Tian Chu and Fuduan Peng and K S Khan and Saxon Rodriguez and Ling Xia and Youming Guo and Alicia Mejia and Sean W. Barnes and Ou Shi and Shreeya Taresh Indulkar and Alaa M. T. Mohamed and Natalie Wall Fowlkes and Timothy Eric Newhook and Yun Shin Chun and Van Karlyle Morris and David Menter and Dadi Jiang and John Paul Shen and Ryan Sun and Jean‐Nicolas Vauthey and Ruoyan Li and Humam N. Kadara and Luisa M. Solis Soto and Scott Kopetz and Linghua Wang and Dipen Maheshbhai Maru},
journal = {Cancer Cell},
year = {2026},
month = jul,
doi = {10.1016/j.ccell.2026.06.009},
url = {https://doi.org/10.1016/j.ccell.2026.06.009},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Spatial multi-omics landscape of colorectal cancer macro- and micrometastases
AU - Yunhe Liu
AU - Akshaya S. Jadhav
AU - Yuwen Pan
AU - Jianlong Liao
AU - Isha Khanduri
AU - Yunhe Liu
AU - Riham Katkhuda
AU - Wei Lü
AU - Kyung Serk Cho
AU - Zhimin Tong
AU - Tieling Zhou
AU - Kangyu Lin
AU - Baohua Sun
AU - Mei Jiang
AU - Sharia D. Hernandez
AU - Idania Carolina Lubo Julio
AU - Patrick M. Brennan
AU - Guangsheng Pei
AU - Kai Yu
AU - Yibo Dai
AU - Tian Chu
AU - Fuduan Peng
AU - K S Khan
AU - Saxon Rodriguez
AU - Ling Xia
AU - Youming Guo
AU - Alicia Mejia
AU - Sean W. Barnes
AU - Ou Shi
AU - Shreeya Taresh Indulkar
AU - Alaa M. T. Mohamed
AU - Natalie Wall Fowlkes
AU - Timothy Eric Newhook
AU - Yun Shin Chun
AU - Van Karlyle Morris
AU - David Menter
AU - Dadi Jiang
AU - John Paul Shen
AU - Ryan Sun
AU - Jean‐Nicolas Vauthey
AU - Ruoyan Li
AU - Humam N. Kadara
AU - Luisa M. Solis Soto
AU - Scott Kopetz
AU - Linghua Wang
AU - Dipen Maheshbhai Maru
PY - 2026
DA - 2026/07/09
JO - Cancer Cell
DO - 10.1016/j.ccell.2026.06.009
UR - https://doi.org/10.1016/j.ccell.2026.06.009
AB - Colorectal cancer (CRC) metastases frequently recur due to minimal residual disease (MRD) and persistent micrometastases after therapy. Here, we performed spatial multimodal profiling using spot-level and high-resolution spatial transcriptomics, multi-regional whole-genome sequencing following laser-capture microdissection, and high-plex protein imaging to map 49 tumors from 19 patients, encompassing paired primary CRC and matched liver (CLiM) and lung (CLuM) metastases. Phylogenetic reconstruction revealed that liver micrometastases (CLiMi) arose from early clonal divergences and harbored a stem-like, quiescent state consistent with metastatic dormancy. Spatially, we uncovered distinct stromal barriers: macrometastases were encapsulated by myofibroblasts, whereas micrometastases were surrounded by immunosuppressive niches characterized by T cell exhaustion and distinct ligand-receptor signaling networks. Notably, we identified a CLiMi-specific six-gene signature associated with MRD status, disease-free survival, and chemotherapy resistance across multiple independent cohorts. These findings elucidate the spatial evolutionary landscape of CRC metastases and provide tissue-based spatially validated biomarkers for surveillance and therapeutic targeting.
SN - 1535-6108
SN - 1878-3686
ER -